Optimized monoclonal antibodies against tissue factor pathway inhibitor (TFPI)

Details for Australian Patent Application No. 2011223710 (hide)

Owner Bayer HealthCare LLC Scholz, P.

Inventors Wang, Zhuozhi; Pan, Junliang; Grudzinska, Joanna; Votsmeier, Christian; Tebbe, Jan; Birkenfeld, Joerg; Wobst, Nina; Bruckner, Simone; Stenig, Susanne; Scholz, Peter

Agent Davies Collison Cave

Pub. Number AU-A-2011223710

PCT Pub. Number WO2011/109452

Priority 61/309,290 01.03.10 US

Filing date 1 March 2011

Wipo publication date 9 September 2011

International Classifications

A61K 39/00 Medicinal preparations containing antigens or antibodies

A61K 39/395 Medicinal preparations containing antigens or antibodies - Antibodies

Event Publications

20 September 2012 PCT application entered the National Phase

  PCT publication WO2011/109452 Priority application(s): WO2011/109452

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011223712-Enriched game play environment (single and/or multi-player) for casino applications

2011223708-Percutaneously deliverable heart valve and methods associated therewith